{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T01:11:30Z","timestamp":1759972290569,"version":"build-2065373602"},"reference-count":15,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T00:00:00Z","timestamp":1754870400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Intensive and Critical Care Nursing"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.iccn.2025.104210","type":"journal-article","created":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T16:34:22Z","timestamp":1755880462000},"page":"104210","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Should delirium be routinely treated with haloperidol? Yes!"],"prefix":"10.1016","volume":"91","author":[{"given":"John W.","family":"Devlin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.iccn.2025.104210_b0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.iccn.2025.104211","article-title":"Should ICU delirium be routinely treated with haloperidol? No!","volume":"91","author":"van den Boogaard","year":"2025","journal-title":"Intensive Crit Care Nurs"},{"issue":"6","key":"10.1016\/j.iccn.2025.104210_b0010","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1055\/s-0044-1791246","article-title":"Pharmacologic treatment strategies for delirium in hospitalized adults: past, present and future","volume":"44","author":"Devlin","year":"2024","journal-title":"Semin Neurol"},{"issue":"1","key":"10.1016\/j.iccn.2025.104210_b0015","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/CCM.0000000000003482","article-title":"Caring for critically ill patients with the ABCDEF bundle: results of the ICU Liberation Collaborative in over 15,000 adults","volume":"47","author":"Pun","year":"2019","journal-title":"Crit Care Med"},{"issue":"9","key":"10.1016\/j.iccn.2025.104210_b0020","doi-asserted-by":"crossref","first-page":"e825","DOI":"10.1097\/CCM.0000000000003299","article-title":"Clinical practice guidelines for the prevention and management of pain, agitation\/sedation, delirium, immobility, and sleep disruption in adult patients in the intensive care unit","volume":"46","author":"Devlin","year":"2018","journal-title":"Crit Care Med"},{"issue":"26","key":"10.1016\/j.iccn.2025.104210_b0025","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1056\/NEJMoa1808217","article-title":"Haloperidol and ziprasidone for treatment of delirium in critical illness","volume":"379","author":"Girard","year":"2018","journal-title":"N Engl J Med"},{"issue":"26","key":"10.1016\/j.iccn.2025.104210_b0030","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1056\/NEJMoa2211868","article-title":"Haloperidol for the treatment of delirium in ICU patients","volume":"387","author":"Andersen-Ranberg","year":"2022","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.iccn.2025.104210_b0035","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1186\/s13054-023-04692-3","article-title":"Efficacy of haloperidol to decrease the burden of delirium in adult critically ill patients: the EuRIDICE randomized clinical trial","volume":"27","author":"Smit","year":"2023","journal-title":"Crit Care"},{"issue":"1","key":"10.1016\/j.iccn.2025.104210_b0040","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1186\/s13054-023-04621-4","article-title":"Haloperidol for the treatment of delirium in critically ill patients: an updated systematic review with meta-analysis and trial sequential analysis","volume":"27","author":"Andersen-Ranberg","year":"2023","journal-title":"Crit Care"},{"issue":"1","key":"10.1016\/j.iccn.2025.104210_b0045","doi-asserted-by":"crossref","first-page":"e15","DOI":"10.1097\/CCM.0000000000006514","article-title":"Advancing delirium treatment trials: recommendation for future research from the NIDUS Delirium Network","volume":"53","author":"Devlin","year":"2025","journal-title":"Crit Care Med"},{"issue":"1","key":"10.1016\/j.iccn.2025.104210_b0050","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s00134-023-07282-7","article-title":"Long-term outcomes with haloperidol versus placebo in acutely admitted adult ICU patients with delirium","volume":"50","author":"Mortensen","year":"2024","journal-title":"Intensive Care Med"},{"issue":"8","key":"10.1016\/j.iccn.2025.104210_b0055","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1097\/CCM.0000000000004976","article-title":"Association between incident delirium treatment with haloperidol and mortality in critically ill adults","volume":"49","author":"Duprey","year":"2021","journal-title":"Crit Care Med"},{"key":"10.1016\/j.iccn.2025.104210_b0060","doi-asserted-by":"crossref","first-page":"e711","DOI":"10.1097\/CCM.0000000000006574","article-title":"A focused update to the clinical practice guidelines for the prevention and management of pain, anxiety, agitation\/sedation, delirium, immobility, and sleep disruption in adult patients in the ICU","volume":"53","author":"Lewis","year":"2025","journal-title":"Crit Care Med"},{"issue":"7","key":"10.1016\/j.iccn.2025.104210_b0065","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/S2213-2600(13)70166-8","article-title":"Effect of intravenous haloperidol on the duration of delirium and coma In critically ill patients (Hope-ICU): a randomised, double-blind, placebo-controlled trial","volume":"1","author":"Page","year":"2013","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.iccn.2025.104210_b0070","article-title":"Role of antipsychotic agents for adjunct sedation","author":"DeGrado","year":"2025","journal-title":"Crit Care Clin"},{"issue":"1","key":"10.1016\/j.iccn.2025.104210_b0075","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.52034","article-title":"Antipsychotics and the QTc interval during delirium in the Intensive Care Unit: a secondary analysis of a randomized clinical trial","volume":"7","author":"Stollings","year":"2024","journal-title":"JAMA Netw Open"}],"container-title":["Intensive and Critical Care Nursing"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0964339725002721?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0964339725002721?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T20:34:19Z","timestamp":1759955659000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0964339725002721"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":15,"alternative-id":["S0964339725002721"],"URL":"https:\/\/doi.org\/10.1016\/j.iccn.2025.104210","relation":{},"ISSN":["0964-3397"],"issn-type":[{"type":"print","value":"0964-3397"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Should delirium be routinely treated with haloperidol? Yes!","name":"articletitle","label":"Article Title"},{"value":"Intensive and Critical Care Nursing","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.iccn.2025.104210","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"104210"}}